ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients
โ Scribed by Michael Tachezy; Katharina Effenberger; Hilke Zander; Sarah Minner; Florian Gebauer; Yogesh K. Vashist; Guido Sauter; Klaus Pantel; Jakob R. Izbicki; Maximilian Bockhorn
- Book ID
- 112101564
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- French
- Weight
- 449 KB
- Volume
- 131
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
W e read with interest the results from the study of serum albu- min and liver metastasis in patients with carcinomas of unknown primary site by Seve et al. 1 We can present some results from our unpublished study in patients with cancer of unknown primary site in which we explored a set of possible
The association of mRNA expression levels of leptin receptors (long isoform: Lep-R(L) and short isoform: Lep-R(S)) in breast cancer tissue with patient prognosis was studied with special reference to the serum leptin level or the leptin mRNA level in tumor tissue. Lep-R(L), Lep-R(S) and leptin mRNA